Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Betamethasone-d5 is intended for use as an internal standard for the quantification of betamethasone (Item No. 20363) by GC- or LC-MS. Betamethasone is a synthetic corticosteroid.1 In vivo, betamethasone (5 mg/kg) reduces bronchoalveolar lavage fluid (BALF) matrix metalloproteinase-2 (MMP-2) and MMP-9 activities, TNF-α levels, and neutrophil number in a mouse model of LPS-induced lung injury. Prenatal administration of betamethasone (0.1 mg/kg) improves neonatal lung function but decreases hippocampal and corpus callosum neuron density and induces motor function deficits in a rabbit model of late preterm birth.2 It also extends gestational length in a rat model of preterm labor induced by high mobility group protein B1 (HMGB1).3 Formulations containing betamethasone have been used in the treatment of inflammatory skin conditions and prenatally to promote fetal lung maturation.
WARNING This product is not for human or veterinary use.
1. Comparative effects of betamethasone, cyclosporin and nedocromil sodium in acute pulmonary inflammation and metalloproteinase activities in bronchoalveolar lavage fluid from mice exposed to lipopolysaccharide. Pulm. Pharmacol. Ther. 12(3), 165-171 (1999).
2. Neurocognitive sequelae of antenatal corticosteroids in a late preterm rabbit model. Am. J. Obstet. Gynecol. 226(6), 850.e851-850.e821 (2022).
3. Betamethasone as a potential treatment for preterm birth associated with sterile intra-